| mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-07 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-05 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
9e-05 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
| mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0008 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |